PATENT CLAIM ANALYSIS

Application Number: 15766821
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2019-02
Patent Classification: ["424", "135100"]

Abstract:
The present disclosure relates to methods for treating various rare genetic disorders which are characterized, in part, by abnormal resistance to insulin and/or hyperglycemia using a glucagon receptor blocking agent. In various embodiments, the present disclosure relates to methods for treating a rare genetic disorder using antigen binding and antagonizing proteins, e.g., fully human antibodies, that specifically bind to and antagonize the function of the human glucagon receptor.

Claim (Index 39):
A method according to  claim 38 , wherein the one or more symptom is hyperglycemia.

Metadata:
- Claim Count in Document: 41.0
- Percentile: 91.0
- Lexical Diversity: 1.52
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15316866', '13900275', '14855274', '15415672', '13301944']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7806592224408982
- 35 USC 102 Novelty (BERT): 0.5304300545555279
- Combined Prediction Score: 0.7556363056523612
- Mean Citation Score: 339.65670200000005
- Max Citation Score: 344.82382
- Similarity Product: 194.58060838207484

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test